MDT

88.42

-0.26%↓

VEEV

282.22

-0.26%↓

A

120.83

+0.49%↑

WBA

11.48

-0.09%↓

HQY

101.21

-1.67%↓

MDT

88.42

-0.26%↓

VEEV

282.22

-0.26%↓

A

120.83

+0.49%↑

WBA

11.48

-0.09%↓

HQY

101.21

-1.67%↓

MDT

88.42

-0.26%↓

VEEV

282.22

-0.26%↓

A

120.83

+0.49%↑

WBA

11.48

-0.09%↓

HQY

101.21

-1.67%↓

MDT

88.42

-0.26%↓

VEEV

282.22

-0.26%↓

A

120.83

+0.49%↑

WBA

11.48

-0.09%↓

HQY

101.21

-1.67%↓

MDT

88.42

-0.26%↓

VEEV

282.22

-0.26%↓

A

120.83

+0.49%↑

WBA

11.48

-0.09%↓

HQY

101.21

-1.67%↓

Search

Minerva Neurosciences Inc

Chiusa

1.64 -1.8

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

1.63

Massimo

1.68

Metriche Chiave

By Trading Economics

P/E

Media del settore

1.929

40.527

Dipendenti

8

Dividendi

By Dow Jones

Utili prossimi

5 ago 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

1.4M

9.7M

Apertura precedente

3.44

Chiusura precedente

1.64

Minerva Neurosciences Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

2 lug 2025, 17:03 UTC

I principali Market Mover

Furniture Companies Rise on U.S. Trade Deal With Vietnam

2 lug 2025, 15:18 UTC

I principali Market Mover

Mogo Shares Rally After Embrace of Bitcoin Into Holdings, Operations

2 lug 2025, 23:45 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

2 lug 2025, 23:45 UTC

Discorsi di Mercato

Nikkei May Trade Rangebound Amid U.S. Tariff Uncertainty -- Market Talk

2 lug 2025, 23:40 UTC

Discorsi di Mercato

Gold Edges Lower Amid Hopes for More Trade Deals -- Market Talk

2 lug 2025, 21:01 UTC

Acquisizioni, Fusioni, Takeovers

AT&T Completes Sale of Entire Remaining 70% Stake in DIRECTV to TPG >T

2 lug 2025, 21:01 UTC

Acquisizioni, Fusioni, Takeovers

AT&T and TPG Close DIRECTV Transaction

2 lug 2025, 20:26 UTC

Utili

Rivian Stock Drops on Sales Decline. The Stakes Are High for the Rest of 2025. -- Barrons.com

2 lug 2025, 20:22 UTC

Discorsi di Mercato

Gold Rises Following Weak ADP Payroll Reading -- Market Talk

2 lug 2025, 20:13 UTC

Discorsi di Mercato

Oil Price Expectations Stable in Dallas Fed Survey -- Market Talk

2 lug 2025, 19:09 UTC

Discorsi di Mercato

Oil Futures Bounce in Defiance of Downbeat Data -- Market Talk

2 lug 2025, 19:08 UTC

Discorsi di Mercato

Dollar Trims Gains as Investors Brace for Cooling Jobs Market -- Market Talk

2 lug 2025, 19:01 UTC

Discorsi di Mercato

U.S. Natural Gas Ticks Up Ahead of Storage Data -- Market Talk

2 lug 2025, 18:08 UTC

Discorsi di Mercato

Fossil Fuels Rule Energy Roost As U.S. Marks Independence -- Market Talk

2 lug 2025, 17:06 UTC

Acquisizioni, Fusioni, Takeovers

BCE: Maple Leafs, Raptors Rights Access Through Long-Term Agreement With Rogers, Subject to League Approvals

2 lug 2025, 17:05 UTC

Acquisizioni, Fusioni, Takeovers

BCE: Access to Content Rights for Toronto Maple Leafs, Toronto Raptors on TSN Secured Through 2043/2044 Season

2 lug 2025, 17:04 UTC

Acquisizioni, Fusioni, Takeovers

BCE: Proceeds of MLSE Stake Sale to Support Financing of Acquisition of Ziply Fiber

2 lug 2025, 17:04 UTC

Acquisizioni, Fusioni, Takeovers

BCE Inc. Concludes Sale of Minority Stake in Maple Leaf Sports & Entertainment

2 lug 2025, 17:02 UTC

Acquisizioni, Fusioni, Takeovers

Rogers Communications: Now Largest Owner With 75% Interest in Maple Leaf Sports & Entertainment

2 lug 2025, 17:02 UTC

Acquisizioni, Fusioni, Takeovers

Rogers Communications Closes Deal to Buy BCE's 37.5% Stake in Maple Leaf Sports & Entertainment for C$4.7B

2 lug 2025, 16:20 UTC

Discorsi di Mercato

Tech, Media & Telecom Roundup: Market Talk

2 lug 2025, 16:20 UTC

Discorsi di Mercato

Cushing Crude Stock Slide Keeps Bid in WTI -- Market Talk

2 lug 2025, 16:20 UTC

Discorsi di Mercato

Health Care Roundup: Market Talk

2 lug 2025, 16:15 UTC

Discorsi di Mercato

Global Commodities Roundup: Market Talk

2 lug 2025, 16:11 UTC

Discorsi di Mercato

Copper Prices Hold Higher on Supply Disruption, Tariff Uncertainty -- Market Talk

2 lug 2025, 16:09 UTC

Discorsi di Mercato

Gold Futures Rise, Recouping Some Losses -- Market Talk

2 lug 2025, 15:59 UTC

Utili

These Stocks Are Moving the Most Today: Tesla, Centene, Apple, Adobe, Rigetti Computing, Greenbrier, and More -- Barrons.com

2 lug 2025, 15:17 UTC

Discorsi di Mercato

Oil Market to Keep Close Watch on U.S. Payrolls -- Market Talk

2 lug 2025, 15:08 UTC

Discorsi di Mercato

Luxury Sector Should Report a Slowdown -- Market Talk

2 lug 2025, 15:00 UTC

Acquisizioni, Fusioni, Takeovers

Glencore: Merger of Viterra With Bunge Global Closed

Confronto tra pari

Modifica del prezzo

Minerva Neurosciences Inc Previsione

Consenso sulla valutazione

By TipRanks

0 ratings

0

Acquista

0

Mantieni

0

Vendi

Notizie finanziarie

$

Chi Siamo Minerva Neurosciences Inc

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone (MIN-101) for the treatment of negative symptoms in patients with schizophrenia, currently submitted an New Drug Application (NDA); and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. The company has a license agreement with Mitsubishi Tanabe Pharma Corporation to develop, sell, and import roluperidone globally excluding Asia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.